Literature DB >> 17243308

Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis.

Felix Ratjen1.   

Abstract

Entities:  

Year:  2006        PMID： 17243308     DOI： 10.1016/j.jpeds.2006.04.030

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

Review 1.  Timing of hypertonic saline inhalation for cystic fibrosis.

Authors:  Mark Elkins; Ruth Dentice
Journal:  Cochrane Database Syst Rev       Date:  2016-12-22

2.  Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance.

Authors:  Federico Cresta; Aldo Naselli; Federica Favilli; Rosaria Casciaro
Journal:  BMJ Case Rep       Date:  2013-04-29

3.  Inhaled hypertonic saline in adults hospitalised for exacerbation of cystic fibrosis lung disease: a retrospective study.

Authors:  Alejandro A Pezzulo; David A Stoltz; Douglas B Hornick; Lakshmi Durairaj
Journal:  BMJ Open       Date:  2012-04-19       Impact factor: 2.692

Review 4.  Nebulised hypertonic saline for cystic fibrosis.

Authors:  Peter Wark; Vanessa M McDonald
Journal:  Cochrane Database Syst Rev       Date:  2018-09-27

5.  Timing of hypertonic saline inhalation for cystic fibrosis.

Authors:  Mark Elkins; Ruth Dentice
Journal:  Cochrane Database Syst Rev       Date:  2020-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.